Company Overview
Snapshot
Founded in March 2023 by Fabian Trumper and Maayan Gal, Arrakis Bio operates with 1–10 employees. The company has secured funding across one round from FLORA Ventures, focusing on developing animal-free collagen and gelatin.
Business overview
Arrakis Bio is a Health Tech & Life Sciences company focused on revolutionizing the production of human collagen and gelatin. The company develops breakthrough technology to create high-quality, pure, and animal-free collagen and gelatin. Arrakis Bio serves markets within the Pharma & Medical Biotechnology sector, specifically targeting the Cosmetic Materials industry with its innovative solutions.
Strategic signal
In July 2023, Arrakis Bio secured seed funding, which aligns with a broader trend of increased investment in sustainable agrifood startups, as highlighted by the launch of an $80M fund by an Israeli VC. This signals investor confidence in the company's potential to disrupt the collagen and gelatin market with its animal-free technology and indicates a strategic focus on sustainable and ethical material production within the life sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- When was Arrakis Bio founded?
- Arrakis Bio was founded in March 2023.
- Who are the founders of Arrakis Bio?
- Arrakis Bio was co-founded by Fabian Trumper and Maayan Gal.
- What is Arrakis Bio's primary focus?
- Arrakis Bio is developing breakthrough technology to produce animal-free, high-quality, and pure human collagen and gelatin.
- Which sector does Arrakis Bio operate in?
- Arrakis Bio operates primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Cosmetic Materials.
- Has Arrakis Bio received any funding?
- Arrakis Bio secured seed funding in July 2023 from FLORA Ventures.